Percutaneous stereotactic radiofrequency lesioning for trigeminal neuralgia: Determination of minimum clinically important difference in pain improvement for patient-reported outcomes

Vishruth K. Reddy, Scott L. Parker, Dennis T. Lockney, Samit A. Patrawala, Pei Fang Su, Robert A. Mericle

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

BACKGROUND:: The Visual Analog Scale (VAS) and the Barrow Neurological Institute Pain Scale (BNI-PS) are 2 patient-reported outcome (PRO) tools frequently used to rate pain from trigeminal neuralgia (TN). Outcomes studies often use these patient-reported outcomes to assess treatment effectiveness, but it is unknown exactly what degree of change in the numerical scores constitutes the minimum clinically important difference (MCID). MCID remains uninvestigated for percutaneous stereotactic radiofrequency lesioning (RFL), a common surgical procedure for TN. OBJECTIVE:: To determine MCID values for the VAS and BNI-PS in patients undergoing RFL. METHODS:: Forty-three consecutive patients with TN who underwent RFL by a single surgeon were prospectively assessed with the VAS and BNI-PS preoperatively and 3 years postoperatively. Three anchors were used to assign each patient's outcome: satisfaction, willingness to have the surgery again, and Health Transition Index. We then used 3 well-established, anchor-based methods to calculate MCID: average change, minimum detectable change, and change difference. RESULTS:: Patients experienced substantial improvement in both VAS (9.81 vs 3.35; P < .001) and BNI-PS (4.95 vs 2.44; P < .001) after RFL. The 3 MCID calculation methods generated a range of MCID values for each of the PROs (VAS, 4.13-8.20; BNI-PS, 1.03-3.30). The area under the receiver-operating characteristic curve was greater for BNI-PS compared with VAS for all 3 anchors, indicating that BNI-PS is probably better suited for calculating MCID. CONCLUSION:: RFL-specific MCID is variable on the basis of the calculation technique. With the use of the minimum detectable change calculation method with the Health Transition Index anchor, the minimum clinically important difference is 4.49 for VAS and 1.16 for BNI-PS after RFL for TN. ABBREVIATIONS:: AUC, area under the receiver-operating characteristic curveBNI-PS, Barrow Neurological Institute Pain ScaleHTI, Health Transition IndexMCID, minimum clinically important differenceMDC, minimum detectable changePRO, patient-reported outcomeRFL, percutaneous stereotactic radiofrequency lesioningTN, trigeminal neuralgiaVAS, Visual Analog Scale.

Original languageEnglish
Pages (from-to)262-266
Number of pages5
JournalNeurosurgery
Volume74
Issue number3
DOIs
Publication statusPublished - 2014 Mar 1

Fingerprint

Trigeminal Neuralgia
Visual Analog Scale
Pain
Health Transition
ROC Curve
Patient Reported Outcome Measures
Patient Satisfaction
Area Under Curve
Outcome Assessment (Health Care)

All Science Journal Classification (ASJC) codes

  • Surgery
  • Clinical Neurology

Cite this

Reddy, Vishruth K. ; Parker, Scott L. ; Lockney, Dennis T. ; Patrawala, Samit A. ; Su, Pei Fang ; Mericle, Robert A. / Percutaneous stereotactic radiofrequency lesioning for trigeminal neuralgia : Determination of minimum clinically important difference in pain improvement for patient-reported outcomes. In: Neurosurgery. 2014 ; Vol. 74, No. 3. pp. 262-266.
@article{3ba5ad26aee6470cb14171bfb332180f,
title = "Percutaneous stereotactic radiofrequency lesioning for trigeminal neuralgia: Determination of minimum clinically important difference in pain improvement for patient-reported outcomes",
abstract = "BACKGROUND:: The Visual Analog Scale (VAS) and the Barrow Neurological Institute Pain Scale (BNI-PS) are 2 patient-reported outcome (PRO) tools frequently used to rate pain from trigeminal neuralgia (TN). Outcomes studies often use these patient-reported outcomes to assess treatment effectiveness, but it is unknown exactly what degree of change in the numerical scores constitutes the minimum clinically important difference (MCID). MCID remains uninvestigated for percutaneous stereotactic radiofrequency lesioning (RFL), a common surgical procedure for TN. OBJECTIVE:: To determine MCID values for the VAS and BNI-PS in patients undergoing RFL. METHODS:: Forty-three consecutive patients with TN who underwent RFL by a single surgeon were prospectively assessed with the VAS and BNI-PS preoperatively and 3 years postoperatively. Three anchors were used to assign each patient's outcome: satisfaction, willingness to have the surgery again, and Health Transition Index. We then used 3 well-established, anchor-based methods to calculate MCID: average change, minimum detectable change, and change difference. RESULTS:: Patients experienced substantial improvement in both VAS (9.81 vs 3.35; P < .001) and BNI-PS (4.95 vs 2.44; P < .001) after RFL. The 3 MCID calculation methods generated a range of MCID values for each of the PROs (VAS, 4.13-8.20; BNI-PS, 1.03-3.30). The area under the receiver-operating characteristic curve was greater for BNI-PS compared with VAS for all 3 anchors, indicating that BNI-PS is probably better suited for calculating MCID. CONCLUSION:: RFL-specific MCID is variable on the basis of the calculation technique. With the use of the minimum detectable change calculation method with the Health Transition Index anchor, the minimum clinically important difference is 4.49 for VAS and 1.16 for BNI-PS after RFL for TN. ABBREVIATIONS:: AUC, area under the receiver-operating characteristic curveBNI-PS, Barrow Neurological Institute Pain ScaleHTI, Health Transition IndexMCID, minimum clinically important differenceMDC, minimum detectable changePRO, patient-reported outcomeRFL, percutaneous stereotactic radiofrequency lesioningTN, trigeminal neuralgiaVAS, Visual Analog Scale.",
author = "Reddy, {Vishruth K.} and Parker, {Scott L.} and Lockney, {Dennis T.} and Patrawala, {Samit A.} and Su, {Pei Fang} and Mericle, {Robert A.}",
year = "2014",
month = "3",
day = "1",
doi = "10.1227/NEU.0000000000000262",
language = "English",
volume = "74",
pages = "262--266",
journal = "Neurosurgery",
issn = "0148-396X",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

Percutaneous stereotactic radiofrequency lesioning for trigeminal neuralgia : Determination of minimum clinically important difference in pain improvement for patient-reported outcomes. / Reddy, Vishruth K.; Parker, Scott L.; Lockney, Dennis T.; Patrawala, Samit A.; Su, Pei Fang; Mericle, Robert A.

In: Neurosurgery, Vol. 74, No. 3, 01.03.2014, p. 262-266.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Percutaneous stereotactic radiofrequency lesioning for trigeminal neuralgia

T2 - Determination of minimum clinically important difference in pain improvement for patient-reported outcomes

AU - Reddy, Vishruth K.

AU - Parker, Scott L.

AU - Lockney, Dennis T.

AU - Patrawala, Samit A.

AU - Su, Pei Fang

AU - Mericle, Robert A.

PY - 2014/3/1

Y1 - 2014/3/1

N2 - BACKGROUND:: The Visual Analog Scale (VAS) and the Barrow Neurological Institute Pain Scale (BNI-PS) are 2 patient-reported outcome (PRO) tools frequently used to rate pain from trigeminal neuralgia (TN). Outcomes studies often use these patient-reported outcomes to assess treatment effectiveness, but it is unknown exactly what degree of change in the numerical scores constitutes the minimum clinically important difference (MCID). MCID remains uninvestigated for percutaneous stereotactic radiofrequency lesioning (RFL), a common surgical procedure for TN. OBJECTIVE:: To determine MCID values for the VAS and BNI-PS in patients undergoing RFL. METHODS:: Forty-three consecutive patients with TN who underwent RFL by a single surgeon were prospectively assessed with the VAS and BNI-PS preoperatively and 3 years postoperatively. Three anchors were used to assign each patient's outcome: satisfaction, willingness to have the surgery again, and Health Transition Index. We then used 3 well-established, anchor-based methods to calculate MCID: average change, minimum detectable change, and change difference. RESULTS:: Patients experienced substantial improvement in both VAS (9.81 vs 3.35; P < .001) and BNI-PS (4.95 vs 2.44; P < .001) after RFL. The 3 MCID calculation methods generated a range of MCID values for each of the PROs (VAS, 4.13-8.20; BNI-PS, 1.03-3.30). The area under the receiver-operating characteristic curve was greater for BNI-PS compared with VAS for all 3 anchors, indicating that BNI-PS is probably better suited for calculating MCID. CONCLUSION:: RFL-specific MCID is variable on the basis of the calculation technique. With the use of the minimum detectable change calculation method with the Health Transition Index anchor, the minimum clinically important difference is 4.49 for VAS and 1.16 for BNI-PS after RFL for TN. ABBREVIATIONS:: AUC, area under the receiver-operating characteristic curveBNI-PS, Barrow Neurological Institute Pain ScaleHTI, Health Transition IndexMCID, minimum clinically important differenceMDC, minimum detectable changePRO, patient-reported outcomeRFL, percutaneous stereotactic radiofrequency lesioningTN, trigeminal neuralgiaVAS, Visual Analog Scale.

AB - BACKGROUND:: The Visual Analog Scale (VAS) and the Barrow Neurological Institute Pain Scale (BNI-PS) are 2 patient-reported outcome (PRO) tools frequently used to rate pain from trigeminal neuralgia (TN). Outcomes studies often use these patient-reported outcomes to assess treatment effectiveness, but it is unknown exactly what degree of change in the numerical scores constitutes the minimum clinically important difference (MCID). MCID remains uninvestigated for percutaneous stereotactic radiofrequency lesioning (RFL), a common surgical procedure for TN. OBJECTIVE:: To determine MCID values for the VAS and BNI-PS in patients undergoing RFL. METHODS:: Forty-three consecutive patients with TN who underwent RFL by a single surgeon were prospectively assessed with the VAS and BNI-PS preoperatively and 3 years postoperatively. Three anchors were used to assign each patient's outcome: satisfaction, willingness to have the surgery again, and Health Transition Index. We then used 3 well-established, anchor-based methods to calculate MCID: average change, minimum detectable change, and change difference. RESULTS:: Patients experienced substantial improvement in both VAS (9.81 vs 3.35; P < .001) and BNI-PS (4.95 vs 2.44; P < .001) after RFL. The 3 MCID calculation methods generated a range of MCID values for each of the PROs (VAS, 4.13-8.20; BNI-PS, 1.03-3.30). The area under the receiver-operating characteristic curve was greater for BNI-PS compared with VAS for all 3 anchors, indicating that BNI-PS is probably better suited for calculating MCID. CONCLUSION:: RFL-specific MCID is variable on the basis of the calculation technique. With the use of the minimum detectable change calculation method with the Health Transition Index anchor, the minimum clinically important difference is 4.49 for VAS and 1.16 for BNI-PS after RFL for TN. ABBREVIATIONS:: AUC, area under the receiver-operating characteristic curveBNI-PS, Barrow Neurological Institute Pain ScaleHTI, Health Transition IndexMCID, minimum clinically important differenceMDC, minimum detectable changePRO, patient-reported outcomeRFL, percutaneous stereotactic radiofrequency lesioningTN, trigeminal neuralgiaVAS, Visual Analog Scale.

UR - http://www.scopus.com/inward/record.url?scp=84896723115&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896723115&partnerID=8YFLogxK

U2 - 10.1227/NEU.0000000000000262

DO - 10.1227/NEU.0000000000000262

M3 - Article

C2 - 24335815

AN - SCOPUS:84896723115

VL - 74

SP - 262

EP - 266

JO - Neurosurgery

JF - Neurosurgery

SN - 0148-396X

IS - 3

ER -